Clinical Trials in Baltimore

Showing 5761-5780 of 23,476 trials

Evaluation of an Investigational Wearable Vital Signs Monitoring Device in Healthy Infants

NCT05910320

The primary objective of this study is to evaluate the feasibility of the use of an investigational wearable vital sign monitoring device in infants.

Congenital Heart Disease in Children

Johns Hopkins University3 participantsStarted May 2023

Baltimore, Maryland, United States

TERMINATEDPhase 2/3< 1 mile

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

NCT04999020

This is a Phase 2/3, double-blind, randomized, placebo-controlled, parallel group, multicenter study to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of ravulizumab in adult participants with dermatomyositis (DM).

Dermatomyositis

Alexion Pharmaceuticals, Inc.38 participantsStarted Nov 2021

Phoenix, Arizona, United States • Irvine, California, United States • Santa Monica, California, United States +108 more locations

Evaluation of an Investigational Wearable Vital Signs Monitoring Device in Healthy Infants

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

Find Trials by Condition in Baltimore

Facilitating Neuroplastic Changes of Acute Stroke Survivors

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

Testicular Evaluation of Azoospermia Using Micro-Ultrasound

Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Effect of Expanding (Gloving) Barrier Precautions for Reducing Clostridium Difficile Acquisition (and Infection) in VA

Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

Pivotal Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates

A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder

MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

A Study in Participants With Non-cirrhotic NASH With Fibrosis

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Observational Maternal COVID-19 Vaccination Study

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

AutoInflammatory Disease Alliance Registry (AIDA)